It has been found that 13% of sporadic colorectal cancer (CRC) show MLH1 hypermethylation, and a BRAF c.1799T>A, p.Val600Glu mutation has often also been identified in tumor DNA (64, 65). This evidence concerns the gene MLH1 and neoplasm.